• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿莫西林与克拉维酸联合制剂:肺部感染的临床与实验室评估

Amoxicillin and clavulanic acid combination: clinical and laboratory evaluation in pulmonary infections.

作者信息

Saroglou G, Paniara-Volika O, Sima A, Paraskevopoulou E, Makris G, Hatzimichelakis N, Vassilopoulos N, Kontomichalou P

出版信息

Clin Ther. 1982;4(6):442-9.

PMID:6980050
Abstract

Twenty-four patients with pulmonary infections (7 pneumoniae, 17 exacerbations of chronic bronchitis) were treated with a combination of 250 mg of amoxicillin and 125 mg of clavulanic acid supplemented by 500 mg of amoxicillin every eight hours. All patients showed good clinical, roentgenological, and bacteriological response. Bacteria were cleared from sputum by the third day of treatment in half of the patients and by the end of treatment in all but one of the others. Pathogens eradicated from sputum, with concurrent clinical cure, included gram-negative bacteria producing cephalosporinases shown to be resistant to the combination drug by both disk and minimal inhibitory concentration determinations.

摘要

24例肺部感染患者(7例肺炎,17例慢性支气管炎急性加重)接受了250毫克阿莫西林与125毫克克拉维酸联合治疗,每8小时补充500毫克阿莫西林。所有患者在临床、影像学和细菌学方面均显示出良好反应。一半患者在治疗第3天时痰液中的细菌被清除,其余患者除1例之外在治疗结束时细菌均被清除。痰液中根除的病原体,同时伴有临床治愈,包括通过纸片扩散法和最低抑菌浓度测定显示对联合用药耐药的产头孢菌素酶革兰氏阴性菌。

相似文献

1
Amoxicillin and clavulanic acid combination: clinical and laboratory evaluation in pulmonary infections.阿莫西林与克拉维酸联合制剂:肺部感染的临床与实验室评估
Clin Ther. 1982;4(6):442-9.
2
Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.阿莫西林-克拉维酸钾,一种耐β-内酰胺酶的抗生素组合。
Clin Pharm. 1984 Nov-Dec;3(6):591-9.
3
In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.在体外研究中比较阿莫西林+克拉维酸与头孢泊肟酯+克拉维酸对革兰氏阳性和革兰氏阴性病原体的β-内酰胺酶阳性临床分离株的敏感性。
J Indian Med Assoc. 2008 Aug;106(8):545-8.
4
Augmentin in acute exacerbations of chronic bronchitis.阿莫西林克拉维酸钾用于慢性支气管炎急性加重期。
J Int Med Res. 1984;12(6):321-6. doi: 10.1177/030006058401200601.
5
[Comparison of amoxicillin and amoxiclav in the therapy of respiratory infections].阿莫西林与阿莫西林克拉维酸治疗呼吸道感染的比较
Plucne Bolesti. 1989 Jul-Dec;41(3-4):187-92.
6
Augmentin treatment of bacterial infections in hospitalised patients.住院患者细菌感染的阿莫西林克拉维酸治疗
N Z Med J. 1982 Aug 11;95(713):542-5.
7
Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.一种新的药代动力学增强型阿莫西林/克拉维酸制剂(2000/125毫克)对包括耐青霉素菌株在内的肺炎链球菌引起的社区获得性肺炎成人患者的疗效。
Int J Antimicrob Agents. 2005 Feb;25(2):110-9. doi: 10.1016/j.ijantimicag.2004.10.007.
8
Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid.阿莫西林与克拉维酸联合治疗呼吸道感染
Int J Clin Pharmacol Ther Toxicol. 1985 Dec;23(12):647-9.
9
[A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
Cas Lek Cesk. 1985 Jun 7;124(23):711-4.
10
The effect of augmentin on sputum beta-lactamase activity in patients with cystic fibrosis.奥格门汀对囊性纤维化患者痰液中β-内酰胺酶活性的影响。
Br J Clin Pract. 1984 May;38(5):188-9.

引用本文的文献

1
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.阿莫西林/克拉维酸:抗菌活性、药代动力学特性及治疗用途的最新进展
Drugs. 1990 Feb;39(2):264-307. doi: 10.2165/00003495-199039020-00008.